tiprankstipranks
Holding FTXH?
Track your performance easily

FTXH ETF Forecast & Price Targets

See the Price Targets and Ratings of:

FTXH Analyst Ratings

Moderate Buy
51ConsensusRatings
47 Buy
3 Hold
1 Sell
Based on the consensus analyst ratings on 51 stocks held in FTXH.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FTXH 12 Months Forecast

Average Price Target

$32.07
Based on 51 Wall Street analysts offering 12 month price targets to FTXH holdings in the last 3 months. The average price target is $32.07 with a high forecast of $39.08 and a low forecast of $25.28. The average price target represents a 21.35% change from the last price of $26.43.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"23":"$23","40":"$40","27.25":"$27.3","31.5":"$31.5","35.75":"$35.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":39.083,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$39.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.074,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$32.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25.277,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$25.28</span>\n  </div></div>","useHTML":true}}],"tickPositions":[23,27.25,31.5,35.75,40],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.43,27.403307692307692,28.376615384615384,29.349923076923076,30.32323076923077,31.29653846153846,32.26984615384615,33.243153846153845,34.21646153846154,35.18976923076923,36.16307692307692,37.136384615384614,38.109692307692306,{"y":39.083,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.43,26.864153846153847,27.29830769230769,27.73246153846154,28.166615384615383,28.60076923076923,29.034923076923075,29.469076923076923,29.903230769230767,30.337384615384615,30.77153846153846,31.205692307692306,31.63984615384615,{"y":32.074,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.43,26.34130769230769,26.252615384615385,26.163923076923076,26.07523076923077,25.986538461538462,25.897846153846153,25.809153846153848,25.72046153846154,25.63176923076923,25.543076923076924,25.454384615384615,25.36569230769231,{"y":25.277,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.53,"date":1682899200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.31,"date":1685577600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.85,"date":1688342400000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.08,"date":1690848000000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.76,"date":1693526400000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.26,"date":1696204800000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.02,"date":1698796800000,"info":"<div>Price: <b>$24<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":24.94,"date":1701388800000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.17,"date":1704153600000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.23,"date":1706745600000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.96,"date":1709251200000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.76,"date":1711929600000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.43,"date":1714521600000,"info":"<div>Price: <b>$26<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$39.08Average Price Target$32.07Lowest Price Target$25.28
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FTXH Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Ultragenyx Pharmaceutical, Inc.
15 Buy
1 Hold
0 Sell
Strong Buy
$93.64
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Beam Therapeutics, Inc.
6 Buy
4 Hold
0 Sell
Moderate Buy
$47.56
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Arvinas Holding Company
12 Buy
2 Hold
0 Sell
Strong Buy
$65.62
xxxxxxxxxxxxxxxxxxxxxxxxxxx
ACADIA Pharmaceuticals Inc.
13 Buy
5 Hold
0 Sell
Moderate Buy
$30.23
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Moonlake Immunotherapeutics
10 Buy
2 Hold
0 Sell
Strong Buy
$74.40

FTXH Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF
Please check back later or explore other ETFs for potential investment opportunities.

FTXH ETF FAQ

What is FTXH’s average 12-month price target, according to analysts?
Based on analyst ratings, FTXH’s 12-month average price target is $32.07.
    What is FTXH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for FTXH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is FTXH a Buy, Sell or Hold?
        FTXH has a conensus rating of Moderate Buy which is based on 47 buy ratings, 3 hold ratings and 1 sell ratings.
          What is FTXH’s price target?
          The average price target for FTXH is $32.07. This is based on 51 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $39.08 ,the lowest forecast is $25.28. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about FTXH?
            FTXH’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 51 Wall Streets Analysts.
              How can I buy shares of FTXH?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis